83 results
Page 2 of 5
8-K
EX-99.1
xm7hbjttkk
28 Apr 11
Key R&D Milestones and Strong Financials
12:00am
8-K
EX-99.1
gpw1p
27 Jan 11
Receives U.S. Regulatory Approval for KOMBIGLYZE™ XR, and First-Line Indication for SPRYCEL® in Fourth Quarter
12:00am
8-K
EX-10.14
8mvm1g4t
17 Aug 09
Other Events
12:00am
8-K
EX-10.12
rgt c5x98n
17 Aug 09
Other Events
12:00am
8-K
EX-99.1
7nrse8703doq hq9olt3
28 Apr 09
Management’s Discussion and Analysis of Financial Condition and Results of Operations
12:00am